title: Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
abstract: OBJECTIVE
  We examined whether the common polymorphisms of the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene are associated with Type 2 diabetes or obesity in the Korean population.
  
  
  METHODS
  We genotyped two common PPARgamma polymorphisms (Pro12Ala and 161C > T) and examined their association with the clinical phenotypes found in 684 patients with Type 2 diabetes mellitus and 291 non-diabetic control subjects.
  
  
  RESULTS
  The 12Ala allele was less frequent in the Type 2 diabetic patients than in the non-diabetic control subjects (0.036 vs. 0.053, P = 0.024). The allele frequencies of the 161C > T polymorphism did not differ between the control and Type 2 diabetic group (0.158 vs. 0.173). In the non-diabetic controls, those with the T allele had lower BMI and fasting serum triglyceride (TG) concentrations than those with the C/C homozygote (22.7 +/- 2.9 vs. 23.8 +/- 3.2 kg/m2, P = 0.002; 1.45 +/- 0.81 vs. 1.65 +/- 0.83 mmol/l, P = 0.03, respectively). The 12Ala-161T haplotype was associated with a decreased risk for Type 2 diabetes (OR = 0.47, P = 0.009), whereas the 12Pro-161T haplotype was associated with lower BMI and lower fasting serum TG (22.5 +/- 2.8 vs. 23.7 +/- 3.2 kg/m2, P = 0.004; 1.41 +/- 0.87 vs. 1.64 +/- 0.79 mmol/l, P = 0.02, respectively).
  
  
  CONCLUSIONS
  The PPARgamma 12Ala allele was associated with a reduced risk of Type 2 diabetes, whereas the PPARgamma 161T allele was associated with lower BMI and fasting serum TG concentrations in the Korean subjects. The subjects with 12Ala-161T haplotypes had a reduced risk of Type 2 diabetes.
authors.affiliation: Department of Internal Medicine, Seoul National University College of Medicine, Chongno-Gu, Seoul, Korea.
authors.forename: M K
authors.initials: MK
authors.lastname: Moon
authors.forename: Y M
authors.initials: YM
authors.lastname: Cho
authors.forename: H S
authors.initials: HS
authors.lastname: Jung
authors.forename: Y J
authors.initials: YJ
authors.lastname: Park
authors.forename: K H
authors.initials: KH
authors.lastname: Yoon
authors.forename: Y A
authors.initials: YA
authors.lastname: Sung
authors.forename: B L
authors.initials: BL
authors.lastname: Park
authors.forename: H K
authors.initials: HK
authors.lastname: Lee
authors.forename: K S
authors.initials: KS
authors.lastname: Park
authors.forename: H D
authors.initials: HD
authors.lastname: Shin
mesh_terms: D000483:Alleles; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007723:Korea / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology / Q000235:genetics*; D047495:PPAR gamma / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D011159:Population Surveillance / Q000379:methods; D014280:Triglycerides / Q000097:blood
chemical_list: D047495:PPAR gamma; D014280:Triglycerides